Increased carriage of macrolide-resistant fecal E. coli following mass distribution of azithromycin for trachoma control

Background: Mass drug treatment with azithromycin (MDA) is part of the WHO-endorsed ‘SAFE’ strategy for trachoma control in endemic communities. MDA has been associated with reduced trachoma prevalence and short-term reductions in other bacterial infections, but can also lead to increased circulatio...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Seidman, Jessica C, Coles, Christian L, Silbergeld, Ellen K, Levens, Joshua, Mkocha, Harran, Johnson, Lashaunda B, Muñoz, Beatriz, West, Sheila K
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2014
Assuntos:
Infectious Diseases
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4121557/
https://ncbi.nlm.nih.gov/pubmed/24659584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ije/dyu062
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares